Lanreotide Subcutaneous and NovoSeven RT
Determining the interaction of Lanreotide Subcutaneous and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-NovoSeven RT with MixPro injection
- Lanreotide Subcutaneous-Novothyrox
- Lanreotide Subcutaneous-Noxafil
- Lanreotide Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Lanreotide Subcutaneous-Noxafil (Posaconazole Injection)
- Lanreotide Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Lansoprazole
- NovoSeven RT-Lansoprazole Delayed-Release Capsules
- NovoSeven RT-Lansoprazole Orally Disintegrating Tablets
- NovoSeven RT-Lansoprazole, Amoxicillin, and Clarithromycin
- NovoSeven RT-Lanthanum
- NovoSeven RT-Lanthanum carbonate